BlackRock Health Sciences Trust II
BMEZ · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $24,072 | $8,194 | -$25,971 | $59,661 |
| % Growth | 193.8% | 131.5% | -143.5% | – |
| Cost of Goods Sold | $0 | -$8,464 | $0 | $0 |
| Gross Profit | $24,072 | $28,875 | -$25,971 | $6,402 |
| % Margin | 100% | 352.4% | 100% | 10.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $356 | $299 | $362 | $6,348 |
| SG&A Expenses | $356 | $299 | $362 | $6,348 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $262 | $95 | -$26,333 | $0 |
| Operating Expenses | $617 | $394 | -$25,971 | $6,348 |
| Operating Income | $927 | $8,464 | $1,540 | $54 |
| % Margin | 3.9% | 103.3% | -5.9% | 0.1% |
| Other Income/Exp. Net | $22,528 | $11,553 | -$28,011 | $0 |
| Pre-Tax Income | $23,455 | $20,017 | -$26,471 | $59,119 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $23,455 | $20,017 | -$26,471 | $59,119 |
| % Margin | 97.4% | 244.3% | 101.9% | 99.1% |
| EPS | 1.77 | 1.44 | -2.1 | -2.55 |
| % Growth | 22.9% | 168.6% | 17.6% | – |
| EPS Diluted | 1.77 | 1.44 | -2.1 | -2.55 |
| Weighted Avg Shares Out | 13,255 | 13,944 | 12,605 | 112,881 |
| Weighted Avg Shares Out Dil | 13,255 | 13,944 | 12,605 | 112,881 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$927 | -$2,006 | $228 | -$54 |
| EBITDA | $23,505 | $20,025 | -$26,471 | $59,119 |
| % Margin | 97.6% | 244.4% | 101.9% | 99.1% |